Skip to main content
Livermore
Livermore
ZHEN

Reata Pharmaceuticals Inc

RETADelisted Sep 26, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001358762

Reata Pharmaceuticals Inc was delisted on Sep 26, 2023; its insiders filed their last Form 4 on Sep 28, 2023; 214 institutions reported holding it in 13F filings for Q2 2023, worth $3.21B in total; no superinvestor held it.

Superinvestors holding RETA, Q2 2023

See all superinvestors

No superinvestor reported holding RETA in Q2 2023.

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of RETA each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q1 2023

    0 superinvestors holding at quarter end

    Sold out
    Duquesne Family Office

  2. Q1 2022

    1 superinvestor holding at quarter end

    Reduced
    Duquesne Family Office (−85.5%)

  3. Q4 2021

    1 superinvestor holding at quarter end

    Reduced
    Duquesne Family Office (−41.5%)

  4. Q3 2021

    1 superinvestor holding at quarter end

    Added
    Duquesne Family Office (+9.1%)
    Sold out
    Maverick Capital

  5. Q2 2021

    2 superinvestors holding at quarter end

    Added
    Maverick Capital (+121.0%)
    Reduced
    Duquesne Family Office (−15.0%)